News We’re Watching – FDA Nixes Neuralink Trials, Layoffs at J&J, Novel Knee Implants
This week, we learned that the US FDA thinks Elon Musk’s Neuralink brain interface device isn’t ready for human trials. Additionally, J&J cut about 300 medtech jobs, Stryker launched a knee implant, and Active Implants’ meniscus replacement device made it to the FDA’s advisory panel calendar.
You may also be interested in...
Reducing Antimicrobial Resistance With Rapid Tests
Widespread implementation of rapid diagnostic tests is critical for decreasing antimicrobial resistance.
Activists Push US Government To Investigate Animal Abuse Charges Against Neuralink and UC Davis
As Neuralink prepares to begin human trials of its Link brain-computer interface device, the Physicians Committee for Responsible Medicine is asking the FDA to investigate possible violations of “good laboratory practice” regulations related to the mistreatment of monkeys in pre-clinical tests of the technology.
AAOS 2022 Roundup: Stryker, Zimmer Biomet, J&J’s DePuy Synthes, Canary Medical
In this first of two roundups, Medtech Insight highlights new product launches and technologies showcased at the annual AAOS conference by three major orthopedics players and medical data company Canary Medical.